| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |